Advertisement
U.S. markets closed

Novartis AG (NVS)

NYSE - Nasdaq Real Time Price. Currency in USD
96.73+0.85 (+0.89%)
At close: 04:00PM EDT
96.77 +0.04 (+0.04%)
After hours: 05:41PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close95.88
Open96.28
Bid95.60 x 900
Ask97.68 x 900
Day's Range96.16 - 97.20
52 Week Range90.93 - 108.78
Volume1,524,598
Avg. Volume1,441,393
Market Cap197.734B
Beta (5Y Monthly)0.46
PE Ratio (TTM)23.59
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield3.78 (3.94%)
Ex-Dividend DateMar 07, 2024
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-22% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for NVS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Novartis AG
    Analyst Report: Novartis AGNovartis is a pharmaceutical company based in Switzerland. Its portfolio is focused primarily on the areas of Immunology, Neuroscience, Oncology, Cardiovascular, Renal, and Metabolic therapies. The company employs more than 78,000 people and its medicines reach more than 280 million people worldwide.
    Rating
    Fair Value
    Economic Moat
    last monthArgus Research
View more